Health Regulators Risk ‘Sleepwalking’ into a Repeat of Drug Trial Disaster
November 14, 2014
(Times Higher Education) – In March this year the Department of Health awarded £4.5 million to the HRA to make the assessment and approval of research in the NHS more efficient. Changes to be brought in under the new scheme include taking legal decisions on clinical research at a central level, rather than by individual NHS Trusts, as is the case at the moment.